Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers

E. Medvedeva, K. Zykov, Herman G. Marin, A. A. Ploskireva, O. A. Svitich, A. Kaira, Dmitry A. Nazarov, I. O. Volynkov, A. A. Kuzin, A. Kubyshkin, A. Tutelyan, Valeriy V. Beregovykh, T. A. Chebotareva
{"title":"Analysis of the Risk of COVID-19 in the Post-Vaccination Period Based on the Results of a Multicenter Study — a Survey of Medical Workers","authors":"E. Medvedeva, K. Zykov, Herman G. Marin, A. A. Ploskireva, O. A. Svitich, A. Kaira, Dmitry A. Nazarov, I. O. Volynkov, A. A. Kuzin, A. Kubyshkin, A. Tutelyan, Valeriy V. Beregovykh, T. A. Chebotareva","doi":"10.15690/vramn13998","DOIUrl":null,"url":null,"abstract":"Background. One of the vulnerable categories of the population during the COVID-19 pandemic has become employees of medical and educational institutions. Timely and properly organized prevention, based on anti-epidemic measures based on vaccination, is necessary not only to reduce the incidence of the disease, but primarily to reduce the severity in case of its occurrence, reduce the risk of hospitalization. Understanding the effectiveness of preventing SARS-CoV-2 infections among healthcare workers is a critical component of occupational health and safety policy and strategy. \nAim — analysis of the incidence of COVID-19 after vaccination among medical staff and teaching staff of medical higher educational institutions. \nMethods. In the period from January to March 2022, a cross-sectional retrospective single-stage online study was conducted (anonymous questionnaires posted on the Anketologist platform). The survey was completed by 6032 respondents (82% efficiency). According to the criteria, 2114 respondents were excluded from the study. The analysis was carried out according to the questionnaires of 3918 respondents, including an assessment of the incidence after vaccination (n = 3668 respondents). \nResults. Fell ill after a double vaccination for 5 months — 663 (16.9%). Unvaccinated respondents reported that within 5 months. prior to the survey, 116 (46.4%) had a laboratory-confirmed new coronavirus infection. Lack of vaccination increased the risk of SARS-CoV-2 (OR 1.78 ± 0.14; 95% CI: 1.34–2.36). Efficiency within 5 months post-vaccination period was 55.5% (95% CI: 42.2–57.7%) for Sputnik V; 71.9% (95% CI: 68.1–85.4%) — Sputnik Light. It was found that gender and age were not a risk factor for the onset of the disease in the post-vaccination period. The presence of a history of previous COVID-19 increased the risk of disease in the post-vaccination period in individuals under 35 years of age (OR 2.323 ± 0.102; 95% CI: 1.903–2.836), aged 36–64 years (OR 2.547 ± 0.086; 95% CI: 2.150–3.016), older than 65 years (OR 1.323 ± 0.280; 95% CI: 0.764–2.290). Respondents with a history of a combination of chronic cardiovascular pathology and past COVID-19 had a higher risk of getting sick in the post-vaccination period (OR 1.338 ± 0.160; 95% CI: 0.977–1.832). \nConclusion. According to the questionnaire, an important factor affecting the risk of COVID-19 in the post-vaccination period is the presence of SARS-CoV-2 before vaccination, which can increase the chance of developing the disease in the presence of other risk factors (chronic pathology, age, smoking, alcohol consumption).","PeriodicalId":178392,"journal":{"name":"Annals of the Russian academy of medical sciences","volume":"90 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the Russian academy of medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15690/vramn13998","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background. One of the vulnerable categories of the population during the COVID-19 pandemic has become employees of medical and educational institutions. Timely and properly organized prevention, based on anti-epidemic measures based on vaccination, is necessary not only to reduce the incidence of the disease, but primarily to reduce the severity in case of its occurrence, reduce the risk of hospitalization. Understanding the effectiveness of preventing SARS-CoV-2 infections among healthcare workers is a critical component of occupational health and safety policy and strategy. Aim — analysis of the incidence of COVID-19 after vaccination among medical staff and teaching staff of medical higher educational institutions. Methods. In the period from January to March 2022, a cross-sectional retrospective single-stage online study was conducted (anonymous questionnaires posted on the Anketologist platform). The survey was completed by 6032 respondents (82% efficiency). According to the criteria, 2114 respondents were excluded from the study. The analysis was carried out according to the questionnaires of 3918 respondents, including an assessment of the incidence after vaccination (n = 3668 respondents). Results. Fell ill after a double vaccination for 5 months — 663 (16.9%). Unvaccinated respondents reported that within 5 months. prior to the survey, 116 (46.4%) had a laboratory-confirmed new coronavirus infection. Lack of vaccination increased the risk of SARS-CoV-2 (OR 1.78 ± 0.14; 95% CI: 1.34–2.36). Efficiency within 5 months post-vaccination period was 55.5% (95% CI: 42.2–57.7%) for Sputnik V; 71.9% (95% CI: 68.1–85.4%) — Sputnik Light. It was found that gender and age were not a risk factor for the onset of the disease in the post-vaccination period. The presence of a history of previous COVID-19 increased the risk of disease in the post-vaccination period in individuals under 35 years of age (OR 2.323 ± 0.102; 95% CI: 1.903–2.836), aged 36–64 years (OR 2.547 ± 0.086; 95% CI: 2.150–3.016), older than 65 years (OR 1.323 ± 0.280; 95% CI: 0.764–2.290). Respondents with a history of a combination of chronic cardiovascular pathology and past COVID-19 had a higher risk of getting sick in the post-vaccination period (OR 1.338 ± 0.160; 95% CI: 0.977–1.832). Conclusion. According to the questionnaire, an important factor affecting the risk of COVID-19 in the post-vaccination period is the presence of SARS-CoV-2 before vaccination, which can increase the chance of developing the disease in the presence of other risk factors (chronic pathology, age, smoking, alcohol consumption).
基于一项多中心研究结果的接种后 COVID-19 风险分析--对医务工作者的调查
背景。在 COVID-19 大流行期间,医疗和教育机构的员工成为易感人群之一。以疫苗接种为基础的抗流行措施是及时和有组织的预防所必需的,这不仅是为了降低疾病的发病率,更主要的是为了在疾病发生时降低其严重程度,减少住院治疗的风险。了解预防医护人员感染 SARS-CoV-2 的有效性是职业健康与安全政策和战略的重要组成部分。目的--分析高等医学院校医务人员和教学人员接种疫苗后 COVID-19 的发病率。方法。在 2022 年 1 月至 3 月期间,开展了一项横断面回顾性单阶段在线研究(在 Anketologist 平台上发布匿名问卷)。共有 6032 名受访者完成了调查(有效率为 82%)。根据标准,2114 名受访者被排除在研究之外。根据 3918 名受访者的问卷进行了分析,包括接种疫苗后的发病率评估(n = 3668 名受访者)。结果。接种双联疫苗 5 个月后发病的有 663 人(16.9%)。未接种疫苗的受访者称,在调查之前的 5 个月内,有 116 人(46.4%)曾感染过实验室确诊的冠状病毒。未接种疫苗会增加感染 SARS-CoV-2 的风险(OR 1.78 ± 0.14;95% CI:1.34-2.36)。接种后 5 个月内的有效率为:斯普特尼克 V 型为 55.5%(95% CI:42.2-57.7%);斯普特尼克 Light 型为 71.9%(95% CI:68.1-85.4%)。研究发现,性别和年龄不是接种后发病的风险因素。35岁以下(OR 2.323 ± 0.102;95% CI:1.903-2.836)、36-64岁(OR 2.547 ± 0.086;95% CI:2.150-3.016)、65岁以上(OR 1.323 ± 0.280;95% CI:0.764-2.290)的受访者在接种COVID-19后发病的风险增加。有慢性心血管病史和既往 COVID-19 病史的受访者在接种疫苗后患病的风险更高(OR 1.338 ± 0.160;95% CI:0.977-1.832)。结论根据问卷调查,影响接种疫苗后患 COVID-19 风险的一个重要因素是接种疫苗前是否感染了 SARS-CoV-2,如果存在其他风险因素(慢性病、年龄、吸烟、饮酒),感染 SARS-CoV-2 会增加患病几率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信